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ABSTRACT 
The objective of this work was to evaluate the effect of a caloric restriction diet with 
and without the administration of Lactobacillus fermentum CRL1446, Lactobacillus 
casei CRL431 and Lactococcus lactis CRL1434, on immune-metabolic parameters and 
the composition of intestinal microbiota in mice.  
The supplementation of the CR diet with L. fermentum CRL1446 showed a bifidogenic 
effect and was able to maintain the abundance of the genus Lactobacillus over time. On 
the other hand, this strain showed hypocholesterolemic and hypoglycemic properties as 
well as inducing a decrease in plasma leptin levels.  
L. casei CRL431 administration increased the abundance of the Lactobacillus genera in 
the intestinal microbiota, which would improve the absorption of nutrients from the 
diet. This strain restores glucose values decreased by the diet in addition to inducing an 
increase in leptin and cytokines. 
Lac. lactis CRL1434 showed greater immunomodulatory capacity, without significantly 
affecting the composition of the intestinal microbiota. It had hypoglycemic properties 
and induced a decrease in leptin concentrations.  
L. fermentum CRL1446 and Lac. lactis CRL1434 could be potentially probiotic strains 
useful to correct the immuno-metabolic alterations associated with obesity, while L. 
casei CRL431 is a more suitable strain to be used in cases of malnutrition where it is 
sought to improve the absorption of nutrients and protection against infections, in 
addition to the stimulation of the immune system. 
Keywords: adipokines, probiotics, microbiota, caloric restriction  
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1. INTRODUCTION  
 
Caloric restriction (CR) is defined as a reduction in energy intake below the number of 
calories consumed ad libitum ( ≥ 10% reduction in humans and usually ≥ 20% reduction 
in rodents)  (Bales & Kraus, 2013). Several researchs had shown that CR can extend 
lifespan in several animal models, ameliorating aging-related diseases (Masaro, 2009). 
The mechanisms by which CR exerts its effects remain controversial (Zhang et al., 
2013). 
The CR favours the phyla that correlate positively with "life expectancy" or longevity, 
such as species belonging to the genus Lactobacillus (Moschen, A. R., Wieser, V., & 
Tilg, H., 2012; Zhang et al., 2013). In addition, these shifts in intestinal microbiota (IM) 
composition with CR can be beneficial in obesity because would induce a decrease 
intestinal permeability and lipopolysaccharide (LPS)-related endotoxemia, and thereby 
reducing chronic low-grade inflammation (Zhang et al., 2013). Furthermore, the IM 
develops an intense metabolic activity, improving the bioavailability of nutrients and 
the degradation of non-digestible compounds, supplying new nutrients (short-chain fatty 
acids, SCFAs), or eliminating harmful anti-nutrients (Krajmalnik-Brown, Ilhan, Kang, 
& DiBaise, 2012). These metabolic functions have a significant impact on the 
nutritional status and health of the host (Ojeda  et al., 2015. However, as mentioned, it 
depends on the composition of the gut microbiota and its complex interactions with the 
individual's diet and genome (Cani, 2014; Cani, 2015; Druart et al., 2015; Sanchez, 
Panahi, & Tremblay, 2015). 
The CR can be explained, from the point of view of evolution, as a compensation 
mechanism that is involved in the metabolic and neuroendocrine responses that living 
organisms use to adapt to periods of deficiency of food (Holliday, 1989). It is well 
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known that a sustainable weight loss over time (between 5% and 10%) in overweight 
and obese individuals is associated with immuno-metabolic improvements (Wing et al., 
2011). However, up to now, the pharmacological approaches have poor long-term 
efficacy in weight management. Thus, new alternatives should be considered to 
maintain the beneficial effect of weight loss efficiently over time. In this sense, several 
authors suggested that the modulation of the IM through different diet interventions or 
the administration of beneficial microorganisms are interesting strategies to alleviate the 
alterations caused by nutritional disorders (Sanz, Santacruz, & Gauffin, 2010). In this 
context, we proposed that the use of non-inflammatory lactic acid bacteria (LAB) 
strains with the capacity to modulate adipokines secretion could be an effective strategy 
for the treatment of metabolic diseases associated with immune abnormalities 
(Fabersani et al., 2017). Furthermore, we suggested that the supplementation of these 
LABs combined with a CR diet could synergize their beneficial effect in such metabolic 
disorders. 
The aim of this work was to evaluate the oral administration of probiotic Lactobacillus 
casei CRL431, Lactobacillus fermentum CRL1446, and Lactococcus lactis CRL1434 
strains in a murine caloric restriction model. These strains were previously selected 
(Fabersani et al., 2017) for their adipo-and immune-modulatory capacity. We analysed 
immune and metabolic parameters and the composition of the IM.  
2. Materials and Methods 
2.1. Bacterial Strains and Culture Conditions 
The strains used in this study were L. casei CRL431 (CRL431), L. fermentum CRL1446 
(CRL436) and Lac.  lactis CRL1434 (CRL1434). LAB strains were obtained from the 
Centro de Referencia para Lactobacilos (CERELA, Tucumán, Argentina) culture 
collection. They were isolated in our laboratory from regional products and stools of 
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healthy infants. The used microorganisms could potentially be considered as probiotic 
strains or as starter cultures for meat or milk fermentation. Probiotic properties 
previously determined were immunomodulation (Villena, Salva, Agüero, & Alvarez, 
2011), adipose tissue modulation (Fabersani et al., 2017), production of conjugated 
linoleic acid (Terán et al., 2015), feruloyl esterase activity (Abeijón Mukdsi, Gauffin 
Cano, González, & Medina, 2012), and protection against intestinal infections 
(Marranzino, Villena, Salva, & Alvarez, 2012). 
Bacteria were cultured in Man–Rogosa–Sharpe (MRS) broth (Britania, Buenos Aires, 
Argentina) at 37°C for 22 h (stationary growth phase). Cells were harvested by 
centrifugation (10,000 rpm for 10 min), washed twice with phosphate-buffered saline 
(PBS, 130 mM sodium chloride, 10 mM sodium phosphate, pH 7.4), and re-suspended 
in PBS containing 20% (v/v) glycerol. Aliquots of these suspensions were frozen and 
stored at −80°C until they were administered to the animals. One fresh aliquot was 
thawed for every day to avoid variability in the viability of cultures in the experiments. 
Cells were then resuspended in sterile drinking water to the desired concentration: 1 × 
10
8
 cells per mL. Bacterial suspensions were prepared freshly every day and changed 
every 12 h. 
 
2.2. Animals and Diets 
Weaned 21-day old male Balb/c mice (n = 40) were obtained from the closed random-
bred colony maintained at CERELA. They were housed in individual cages and 
acclimated to 22 ± 2°C with a 12 h light/dark cycle. They were then separated into the 
following five groups (n=8 each group): standard diet (SD), caloric restriction diet 
(CRD), CRD supplemented with CRL1446 (CRD-CRL1446), CRD supplemented with 
CRL1434 (CRD-CRL1434) and, CRD supplemented with CRL431 (CRD-CRL431). 
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The composition of SD was; 61% carbohydrates, 23% proteins, 7.5% fats, 4% raw 
fibre, 3.5%, total minerals (3.10 Kcal/g) (Asociación de Cooperativas Argentinas, 
Buenos Aires, Argentina). The SD group was ad libitum fed with SD and drinking 
water for 45 days. Animals from CRD groups were acclimated for 5 d to ad libitum SD 
and after this period they were daily fed with a restricted size of SD (25% less than the 
daily ration) during 45 days in order to reach a 10%–25% body weight loss compared to 
mice from SD Group. CRD-CRL groups were fed with CRD supplemented with 
CRL1446, CRL431 or CRL1434 strains in the drinking water at the dose of 10
8
 
cells/mL.  
 Body weight was measured weekly and caloric intake was accounted for daily food 
consumption. At the end of the study, animals were fasted for 12 h, anaesthetized, bled 
by aortic puncture, and sacrificed by cervical dislocation. For analysis of metabolic 
parameters, blood samples were collected in tubes containing EDTA and centrifuged to 
obtain plasma, which was kept at -20 ºC. The faecal contents were collected at the end 
of the experimental period (day 45) for microbiological analyses. The white adipose 
tissue (epididymal) was processed for histological analysis. 
The experiments were carried out in strict accordance with the recommendations of the 
Guide for the Care and Use of Laboratory Animals Center of CERELA and the study 
protocol was approved by the Ethical Committee (approval number CRL-BIOT- EF-
2012 /2A). 
2.3. DNA Extraction from Intestinal Contents and High-Throughput Sequencing 
(HTS) of 16S rRNA Gene Amplicons 
Fifty milligrams of intestinal contents were homogenized in 500 µL of 10 mg/mL 
lysozyme solution in Tris-Sucrose buffer (50 mM Tris-HCl, 40 mM EDTA, 0.75 M 
sucrose, pH 8.0) and incubated for 1 h at 37 °C. Total DNA was purified using the 
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Maxwell R 16 DNA Purification Kit and the Maxwell R 16 Instrument (Promega, 
Madison, WI, USA), according to the manufacturer’s instructions. 
The bacterial V3-V4 16S rRNA regions were amplified by PCR.  The primer pairs used 
were 343F (5′-TACGGRAGGCAGCAG-3′) and 802R (5′-
TACNVGGGTWTCTAATCC-3′) according to Polka et al. (Połka, Rebecchi, Pisacane, 
Morelli, & Puglisi, 2015). The PCR product pool was sent to Fasteris SA (Geneva, 
Switzerland) to be sequenced using the TruSeq™ DNA sample preparation kit (Illumina 
Inc., San Diego, CA, USA). High-throughput sequencing was carried out in one lane 
MiSeq Illumina instrument (Illumina Inc.) using the V2 chemistry in a 2 × 250 
configuration sufficient to cover the entire amplicon length, estimated to be ~450 bp. 
Paired-end assembly and quality filtering were performed by using Flash software 
(Magoč & Salzberg, 2011). Sample de-multiplexing was carried out using DNA 
barcoding information per sample and Mothur platform. The assembled and 
barcode/primer-free sequences were processed for chimera removal using Uchime 
algorithm (Edgar, Haas, Clemente, Quince, & Knight, 2011) and SILVA reference set 
of 16S sequences (Quast et al., 2013). 
Diversity indexes were calculated with Mothur platform using default parameters and 
average method in the clustering step (Schloss et al., 2009). Different alpha diversity 
parameters (Sobs and Chao’s richness, Shannon’s diversity) and evenness indexes were 
computed from Operational Taxonomic Units (OTUs). OTUs clustered at 97% and 
using a normalized subset of 23,000 sequences randomly selected after multiple 
shuffling (10,000×) of the original dataset. Taxonomy assignation at Phylum and Genus 
levels of the subset of high-quality reads was performed with Bayesian RDP Classifier 
(Wang, Garrity, Tiedje, & Cole, 2007), using an assignment confidence cutoff 0.8. Beta 
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diversity was analysed by performing Unifrac-weighted analysis (Lozupone, Lladser, 
Knights, Stombaugh, & Knight, 2011). 
2.4. Biochemical assays 
Plasma triglycerides, total cholesterol, glucose and leptin were measured by enzymatic 
methods using commercial kits (Wiener Lab, Rosario, Argentina). The plasma leptin 
levels were determined by enzyme-linked immunosorbent assay (Mouse / Rat Leptin 
Quantikine ELISA Kit, MN, USA). The plasma IL-2, IL-4, IL-6, IFN-γ, TNF-α, IL-17A 
and IL-10 were quantified using the BD ™ kit (CBA Th1 / Th2 / Th17 Mouse, BD 
Bioscience, # 560485, CA, USA). The limit of detection for this kit was 0.1 pg / mL 
(IL-2), 0.03 pg / mL (IL-4), 1.4 pg / mL (IL-6), 0.5 pg / mL (IFN-γ), 0.9 pg / mL (TNF-
α), 0.8 pg / mL (IL-17A) and 16.8 pg / mL (IL-10). The concentration of MCP-1 
(eBioscience, Inc., Mouse CCL2 (MCP-1) Ready-Set-Go! ®, CA, USA)  
2.5. Isolation of peritoneal macrophages to evaluate their ex vivo functionality  
Peritoneal cells were collected by washing the peritoneal cavity of mice from the 
different groups (45 d), with 5 mL of sterile cold Dulbecco's Modified Eagles Medium 
(DMEM) (Gibco, #41965-039, CA, USA), containing 10% inactivated (56 ºC for 30 
min) fetal bovine serum (Gibco, 10082139,CA,USA), 100 µg/mL streptomycin, and 
100 U/mL penicillin (Sigma ALDRICH P 4333, MO, USA). Isolated macrophages were 
plated into the flasks (Costar® 24, NY, USA) at a concentration of 10
6
 cells/mL in 
DMEM and incubated for 2 h at 37ºC in an atmosphere containing 5% CO2, and non-
adhered cells were washed out with warm PBS.  
To evaluate the functionality of macrophages, adhered macrophages were cultured 
overnight into 24-well flat-bottom polystyrene microtiter plates (Costar® 24 well flat, 
#3524, NY, USA) at the concentration of 1x10
5
 cells/mL in DMEN. The media were 
changed before LAB stimulation, and then, macrophages were incubated in the presence 
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of 100 µl of a cell suspension 1x10
7
 CFU/ml of each strain for 24 h. Macrophages from 
different mice groups were also incubated in the presence of purified LPS from E. coli 
serotype O26:B6 (SIGMA-ALDRICH, # L2654, MO, USA) at a concentration of 1 
µg/mL. Non-stimulated peritoneal macrophages were also evaluated as controls of basal 
cytokine production. Cell viability was evaluated with Trypan-blue (SIGMA-
ALDRICH, # T6146, MO, USA). The cell culture supernatants were collected and 
stored at -20ºC until used for cytokine determination. The cytokines were determined in 
the supernatants of stimulated and non-stimulated cells as previously mentioned in point 
2.4. The tests were carried out according to the manufacturer's instructions. Each 
parameter was determined in triplicate in two independent experiments. 
2.6. Isolation of adipocytes to evaluate their ex vivo functionality 
  Adipocytes from the epididymal adipose tissue of the mice from the different groups 
(45 d) were isolated by collagenase digestion (Collagenase from Clostridium 
histolyticum Type II  #C6885 SIGMA, USA.) as previously described (Bernstein, Hyun, 
Davis, Fulwyler, & Pershadsingh, 1989). Briefly, adipose tissues from 4-6 mice were 
pooled for adipocyte isolation. Tissue was digested during 1 h incubation period at 37°C 
in DMEM high glucose supplemented with 10% (v/v) fetal bovine serum, 
penicillin/streptomycin and containing 1,5 mg/ml collagenase II under constant 
agitation. The suspension was subsequently centrifuged at 400 rpm for 5 min at room 
temperature. The mature adipocyte floated to the surface, and the stromal-vascular cells 
(capillary, endothelial, mast, macrophage, and epithelial cells) were deposited at the 
bottom. The stromal-vascular cells were removed by aspiration, and the fat cells were 
washed with 10 ml of DMEM high glucose supplemented with 10% FBS and 
penicillin/streptomycin and centrifuged at 400 rpm for 2 min. This procedure was 
repeated twice. Two aliquots (10 µl) of cell suspension were stained with Trypan-blue 
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and counted on a hemocytometer to estimate the concentration of adipocyte cells. 0.5 
mL suspension of adipocyte cells in plating medium was inoculated into 24-well plates 
at a concentration of 5 x 10
5
 cells/wells. The cells were maintained in a humidified 5% 
CO2 atmosphere for 24 h at 37°C. The media were changed before LAB stimulation, 
and then, adipocytes were incubated in the presence of 100 µl of a cell suspension 1x10
7
 
CFU/ml of each strain for 24 h. Then, adipocytes from different mice groups were also 
incubated in the presence of purified LPS from E. coli serotype O26: B6 (SIGMA-
ALDRICH, # L2654, MO, USA) at a concentration of 1 µg/mL. Non-stimulated 
adipocytes were also evaluated as controls of basal leptin production. Cell viability was 
evaluated with Trypan-blue (SIGMA-ALDRICH, # T6146, MO, USA). The cell culture 
supernatants were collected and stored at -20ºC until used for cytokine determination. 
The leptin levels were determined in the supernatants of stimulated and non-stimulated 
cells by enzyme-linked immunosorbent assay (Mouse / Rat Leptin Quantikine ELISA 
Kit, MN, USA). 
2.7. Histological analysis of adipocytes  
Paraffin-embedded epididymal adipose tissues were sectioned to a thickness of 4-5 µm 
and fixed to glass slides. Slides were deparaffinised and stained with hematoxylin-eosin. 
The adipocyte number and sizes of each group were determined according to the 
methodology described by Gauffin-Cano et al. (Gauffin Cano, Santacruz, Trejo, & 
Sanz, 2013) using the Carl Zeiss-Axio Vision software, Release 4.8. Adipocyte number 
and sizes were measured in 100 cells of two sections of epididymal adipose tissue per 
mouse (n=8 each group). Adipocyte sizes were expressed as area ranges using the 
following ranges areas: <500; 500-1000; 1,000-2,000; 2,000-4,000; and > 4,000 μm2 to 
be able to compare between the different groups. 
2.8. Statistical analysis 
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The experiences in animals were performed twice (40 mice each experience), and the 
determinations were repeated in triplicate. The results were expressed as means ± 
standard error mean (SEM). The data were analysed with the SPSS program version 
17.0 (SPSS Inc., Chicago, IL, USA). The data were normally distributed and significant 
differences were determined by applying One and Two-way ANOVA with post hoc 
Tukey’s test or Fisher’s least significant difference test. In every case, P-values <0.05 
were considered statistically significant. 
 
3. Results and discussion 
In this work, we used a caloric restriction model that is achieved with a restriction of 
25% of the daily food consumed, which induced an approximately 24% loss of body 
weight at 45 d of treatment. Usually, the loss of body weight can be related to moderate 
(26-39%) or severe (> 40%) malnutrition; the latter, which may have a high mortality 
(Gómez et al., 2000). Unlike these, our caloric restriction model could be considered a 
model of CR “without malnutrition”. There are many epidemiological and clinical 
studies that suggest that a CR diet without malnutrition may be beneficial, decreasing 
the incidence of cardiovascular disease, type 2 diabetes, and different types of cancer in 
humans (Anderson and Weindruch, 2010). Various studies have shown that CR without 
malnutrition delays the aging process and prolongs the half-life of various species 
(Spindler, 2010).  However, the mechanisms by which this occurs are still not 
completely known. The inverse linear relationship between calorie intake and half-life 
suggests that the regulators of energy metabolism are important for the effects 
attributing to CR (Anderson and Weindruch, 2010). Nevertheless, the evaluation of the 
metabolic response to the CRD is a field that is not completely clarified and requires 
additional studies. In order to provide more knowledge about the effect of that 
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“beneficial” CR on health status prevalence, we evaluate the effects in mice of a CRD 
with and without the oral administration of different “adipokine-modulatory” LAB 
(bacteria that has the indirect ability to stimulate the secretion of adipokines): L. 
fermentum CRL1446, L. casei CRL431 and Lac. lactis CRL1434 (Fabersani et al., 
2017). Effects on metabolic and immunological parameters and the structure of the 
intestinal microbiota were evaluated in two periods of time, at days 20 and 45, with the 
additional purpose of analysing the impact of time as a variable. 
3.1. Effect of CRD supplemented with LAB on body weight gain (BWG) and feed 
conversion ratio (FCR) 
The Fig 1A shows the effect of the different dietary treatments on body weight gain 
(BWG), at days 7, 20 and 45. We observed that CRD induced a significant reduction in 
BWG compared to the SD. The supplementation of the CRD with LAB also produced 
significant effects on the BWG. CRL431 strain induced a significant increase in BWG 
compared with CRD group (24% at day 20 and 21% at day 45), while the 
supplementation with CRL1446 and CRL1434 strains significantly reduced the BWG. 
On the other hand, at day 7 (when CRD still does not induce significantly change on 
BWG), CRL1446 and CRL431 strains showed a different effect with respect to the 
CRD. Although CRL1446 reduced BWG, CRL431 increased it. The food intake allows 
evaluating the capacity of an organism to transform grams of food consumed in grams 
of body weight. This is defined as feed conversion or feed conversion ratio (FCR). The 
Fig 1B shows the FCR, at days 7, 20 and 45. Our results indicate that the CRD 
significantly decreases the FCR after 20 days of treatment. The administration of LAB 
also induced significant changes in this parameter. CRL1446 and CRL1434 strains 
significantly reduced FCR in comparison with the CRD group. On the other hand, the 
supplementation of CRD with CRL431 significantly increased FCR at all studies times 
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compared with the CRD group. A strong strain-dependent effect on the BWG and FCR 
was demonstrated, that suggests a modulatory effect on the energetic metabolism (since 
all the animals of the CRD groups consumed the same amount of feed).  These results 
suggest a different energy extraction capacity by each group of animals. The efficiency 
to extract energy from the diet is closely related to the structure of the microbial 
community (Bäckhed et al., 2004; Turnbaugh et al., 2009). Various effects of the 
administration of probiotics have been reported on the BWG and the accumulation of 
body fat. Raoult et al. suggest that probiotics, mostly microorganisms from the phylum 
Firmicutes, and particularly Lactobacillus spp genera, could be related to both the 
control of body weight and the development of obesity (Raoult, 2009). These authors, 
also described in children under diarrhoea treatment, an increase of BWG after received 
Lactobacillus spp. Contrary, Ehrlich and Delzenne and Reid affirm that probiotics are 
not related to the development of obesity since the humanity has been consuming 
probiotics without inducing obesity (Delzenne & Reid, 2009; Ehrlich, 2009). In this 
regard, Kang et al. demonstrated that the administration of Lactobacillus gasseri 
BNR17 induced a reduction in body and white adipose tissue weight in overweight rats 
(Kang et al., 2013). In line with this, other authors reported beneficial effects of 
Lactobacillus in diet-induced obesity models (Novotny Núñez, Maldonado Galdeano, 
de Moreno de LeBlanc, & Perdigón, 2015; Tomaro-Duchesneau et al., 2014; 
Toshimitsu, Mochizuki, Ikegami, & Itou, 2016; Yoo et al., 2013) 
3.2. Effect of the CR diet supplemented with LAB on the structure of adipose 
tissue (AT)  
We analysed the AT weight (Fig. 2A), and the number of adipocytes into different area 
ranges (distribution of adipocyte size) (Fig. 2B and 2C) in all the studied experimental 
groups. Significant differences in the AT weight were observed. The CRD induced a 
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significant reduction in AT weight (Fig.2A) of 18% at day 20 and 24% at day 45 with 
respect to the SD group. Supplementation of the CRD with CRL431 completely 
restored the AT weight at day 20 and partially at day 45. While the supplementation 
with CRL1446 and CRL1434, induced a reduction of TA weight of about 22% at day 
20, in comparison with the CRD groups. Regarding the analysis of adipocyte area, the 
CRD favoured a significant increase in the number of adipocytes of a smaller area 
(between 0-500 and 500-1000 μm2) and the reduction in the number of adipocytes of a 
greater area (between 1000-2000 and ≥2000 μm2) with respect to the SD (Fig. 2B and 
2C). Supplementation with CRL1446 induced significant changes at day 45 (Fig.2C), 
causing a large increase of small adipocytes with an area of 0-500 μm2. 
The changes observed in the BWG were associated with changes in the size of the AT 
weight and the area of adipocytes. We suggest that the effect on the BWG is strain 
dependent, and it is mainly due to changes in the structure of the AT induced by the diet 
and/or the synergism between LAB and diet. Sato et al already mentioned a close 
relationship between the administration of a product containing a Lactobacillus and the 
decrease in the size of adipocytes (Sato et al., 2008). According these authors, the 
decrease in adipocyte size could be one mechanisms for preventing obesity due to the 
inhibition of hypertrophy and hyperplasia. Futhermore, previous research suggested that 
adipocyte size is a significant indicator for the future development of metabolic disease 
(Weyer, Foley, Bogardus, Tataranni, & Pratley, 2000). Adipose tissue is not only an 
energy storage organ, but it is also an endocrine and immune organ able to secrete 
hormones and cytokines, known as adipokines, with implications in immune function 
and energetic homeostasis (Antuna-Puente, Feve, Fellahi, & Bastard, 2008; Grant & 
Dixit, 2015; Sam & Mazzone, 2014)  
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3.3. Effect of the CRD supplemented with LAB on plasma metabolic parameters 
and cytokines. 
In the Fig. 3A, B, C, D we showed the effects of CRD and LAB in the glucose, total 
cholesterol, triglycerides and leptin levels. Our results revealed that the CRD 
significantly reduce the levels of these metabolites in plasma at days 20 and 45, 
compared with SD animals.  
3.3.1. Glucose 
The supplementation of the CRD with CRL1446 and CRL1434 at day 45 induced a 
significant decrease in glucose with respect to the CRD group (Fig. 3A). The 
administration of the CRL431 strain for 20 days increase glucose levels to values 
similar to those of SD groups.  (Fig. 3A). These results show the modulatory effect of 
LAB on glucose metabolism and may be related to the modulation of leptin levels, 
which affects the sensitivity of insulin and therefore glucose levels (Al-Jada & Ahmad, 
2014).  
3.3.2. Leptin and triglyceride 
We showed that the CRD was adipokine-modulatory by itself, since it significantly 
reduced leptin levels (about 70% reduction) compared with the SD (Fig. 3D). The 
administration of CRL431 induced a significant increase in leptin levels (about 32%) 
with respect to the CRD group. In contrast, supplementation with CRL1446 and 
CRL1434 only had an effect at day 45, where they induced a significant reduction in 
leptin levels (about 50%) compared with the CRD control.  
The CRD diet was the only treatment responsible for the decrease in triglycerides. On 
the other hand, we did not observe significant effects with any strain on triglyceride 
levels (Fig. 2C). However, previously we showed that the administration of other 
beneficial bacteria, as Bifidobacterium pseudocatenulatum CECT7765 and  Bacteroides 
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uniformis CECT7771, were able to reduce plasma triglycerides levels in obese mice. 
This effect was not observed in  lean mice (Gauffin Cano et al., 2013; Gauffin Cano, 
Santacruz, Moya, & Sanz, 2012).  
Leptin is a pleiotropic hormone and is regulated by numerous factors. One of them is 
the size of the adipocytes, which depends on the plasma levels of triglycerides, either 
coming from the diet or synthesized de novo (liver). Strains CRL1446 and CRL1434 
were considered hypoleptinemic; however, we did not observe changes in triglyceride 
levels in addition to those induced by the CRD. But, we observed changes in the size of 
adipocytes (Fig 2B and 2C), probably due to changes in adipocytes turnover. 
Furthermore, the modulation of leptin in these experimental conditions could be also 
related to changes in its secretion by other cells. 
3.3.3. Cholesterol 
When we analysed the total cholesterol values, we observed that only CRL1446 strain 
significantly reduced it compared to the control of CRD group (Fig. 3B). Some authors 
(Fontana, Meyer, Klein, & Holloszy, 2004) showed that CRD has beneficial effects on 
cardiovascular risk factors such as atherosclerosis, serum cholesterol, LDL-cholesterol, 
HDL-cholesterol and triglyceride (which usually increase with advancing age). These 
authors also showed that CRD provides a powerful protective effect against obesity and 
insulin resistance. Approximately, up to 1 g of dietary cholesterol enters the colon, and 
despite the enormous variations observed among individuals, only half of this dietary 
cholesterol is absorbed on average, mainly in the duodenum and the proximal jejunum 
(Gérard, 2013). In addition to the cholesterol from the diet, serum levels can be 
maintained by de novo synthesis that occurs mainly in the liver. Since CRD also affects 
the structure of the intestinal microbiota (Fig 6), it could indirectly alter the metabolism 
of hepatic cholesterol and the de novo synthesis of this lipid (Caesar, Nygren, Orešič, & 
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Bäckhed, 2016). Changes in the predominant phyla (i.g., prevalence of Firmicutes and 
Bacteroidetes) has been shown to affect the extraction of energy from the diet and 
therefore the levels of metabolites in the blood (Bäckhed et al., 2004; Jumpertz et al., 
2011).  In our experimental model, CRL1446 had a hypocholesterolemic effect and 
could be acting synergistically with the CRD.  We previously demonstrated that 
CRL1446 has been shown to have a high feruloyl esterase activity  (Abeijón Mukdsi et 
al., 2012)  and could probably be the mechanism of action by which this strain exerts its 
hypocholesterolemic effect, in addition to the modifications that induces on the gut 
microbiota. In concordance, Bhathena et al. reported that the feruloyl esterase  
producing strain, L. fermentum LF11976, decreased serum lipids in 
hypercholesterolemic hamsters (Bhathena, 2013). This assertion is based on the fact that 
the ferulic acid has hypocholesterolemic properties, since it can inhibit 
hydroxymethylglutaryl CoA reductase (a limiting enzyme in the biosynthesis of 
cholesterol) and cholesterol acyltransferase (enzyme that esterifies cholesterol in the 
tissues, mainly in the liver), and can increase the excretion of acid sterols 
(Balasubashini, Rukkumani, & Menon, 2003). 
3.3.4. Cytokines 
Concerning the immune status, the levels of the following cytokines were determined in 
plasma at day 45  of intervention: IL-2, IL-4, IL-6, IL-10, IL-17, IFN-γ, TNF-α and 
MCP-1. However, we only observed significant changes in the levels of TNF-α and IL-
10 (Fig. 4A and B). The CRD significantly reduced TNF-α levels compared to SD. The 
supplementation with CRL1434 and CRL431 induced a significant increase in the levels 
of IL-10 compared to SD and CRD groups. These strains had an important modulatory 
capacity since they were able to induce a significant increase of IL-10 levels. IL-10 is a 
regulatory cytokine, which inhibits the expression of pro-inflammatory cytokines such 
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as TNF-α or IL-6 (Opal & Depalo, 2000). Some authors demonstrated a relationship 
between insulin resistance and levels of this cytokine (Kim et al., 2004). Also, that 
higher IL-10 levels can protect from high-fat-diet-
induced obesity and glucose intolerance in mice (Gao et al., 2013). Cytokines act in 
concert to regulate the human immune and metabolic response. If we analyse together 
plasma levels of leptin and TNF-α (two pro-inflammatory molecules), we could infer 
that the reduction of these adipokines by CRD are associated with the decrease in AT 
weight and plasma lipid. Similar results were previously reported by other authors 
(Fontana, Klein, & Holloszy, 2010; Fontana et al., 2004). The multiple effects of leptin 
on immune system suggest that immunomodulation by leptin may have therapeutic 
potential in a variety of diseases (Farooqi & O’Rahilly, 2014). Thus, leptin and TNF-α 
are positively correlated with the increase of AT mass (Faggioni, Feingold, & Grunfeld, 
2001), inflammation, and the development of chronic diseases linked to diet such as 
obesity and type 2 diabetes  (Rose, Komninou, & Stephenson, 2004).  
Therefore, we can suggest that the capacity of CRD to modulate these adipokines 
secretion (such as leptin and TNF-α) could be one of the main mechanisms by which 
this diet (CR) prolongs the half-life of different species (Colman et al., 2009). It has 
been established that the main adipokines that influence the adipo-insular axis 
(relationship between AT and pancreatic β-cells), are leptin, adiponectin and TNF-α 
(Dunmore & Brown, 2013). Most studies suggest that leptin and TNF-α induce a 
decrease on the synthesis and secretion of insulin by β-pancreatic cells (Andreev, Paz-
Filho, Wong, & Licinio, 2009; Dunmore & Brown, 2013). Then, this adipo-insular axis 
may participate in the inhibitory feedback mediated by leptin on insulin secretion to 
decrease adipogenesis.  
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3.4. Effect of the CRD and LAB administration on the functionality of murine 
adipocytes and peritoneal macrophages 
3.4.1. Adipocytes 
The functionality of ex vivo adipocytes was evaluated through the production of leptin 
(Fig. 5A and B). The adipocytes obtained from the epididymal AT of the different 
groups showed a different profile of leptin production. The amount of leptin produced 
by unstimulated adipocytes was considered as basal values (DMEM, basal control). 
While, adipocytes stimulated with LPS were considered as control of the stimulation 
(LPS, control (+)). Our results showed that the CRD induced a reduction on basal leptin 
levels, and including those measured in LPS-stimulated adipocytes. Previously, several 
authors have been reported that leptin levels are directly proportional to the size of 
adipocytes (Skurk et al., 2007). Thus, reduction in leptin values may be related to the 
reduction in the adipocytes size of CRD group.  
Our study demonstrated that adipocyte capacity to release leptin was strain-dependent. 
At day 45, the administration of CRL1446 and CRD-CRL1434 groups induced a 
significant reduction in the leptin production by LPS-stimulated adipocytes, with 
respect to the CRD group. In addition, at day 45 of treatment, the LPS-stimulated 
adipocytes from CRD-CRL431 group produced significantly high levels of leptin in 
comparison with LPS-stimulated adipocytes from CRD-CRL1446 and CRD-CRL1434 
groups (Fig. 5B). From the immunological point of view, the leptin is an adipokine 
which can elicit a pro-inflammatory immune response against pathogenic bacterial 
stimulus (like as LPS). The different studies showed an extensive actions of leptin on 
immune responses (Lago, Gómez, Lago, Gómez-Reino, & Gualillo, 2008). The CRD 
associated to CRL431 could promote the ability of adipocyte cells to produce 
appropriate leptin response and, consequently, may contribute to the immune response 
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against an infection (Gauffin Cano & Perdigon, 2003). While, with the other strains 
(CRL1446 and CRL1434), the leptin decrease could be reinforce their 
hypocholesterolemic and hypoglycemic effects. 
3.4.2. Peritoneal macrophages 
The functionality of ex vivo peritoneal macrophages was assessed by the production of 
the TNF-α, IL-6 and IL-10 cytokines and MCP-1 chemokine (Fig. 5C – J). We 
observed that the CRD induced a reduction of both, the basal (DMEM) and the LPS-
stimulated cytokines and chemokine production compared with SD group. In general, 
the supplementation with CRL1434 and CRL431 favour the basal production of TNF-α, 
IL-6, (pro-inflammatory molecules), and IL-10 (regulatory cytokine). While CRL1446 
only induce change in IL-10 after LPS stimulus with respect to the CRD group at day 
45 (Fig. 5C, D, E, F, I and J).  
 Although there was a reduction in the levels of cytokines induced by CRD, peritoneal 
macrophages may respond appropriately to a pro-inflammatory stimulus such as LPS, 
which indicates that they maintained their functionality under this regimen (Fig. 5C, D, 
E, F, I and J). After LPS stimulus at day 20 of treatment the levels of TNF-α, IL-6 and 
IL-10 were significantly higher in the groups supplemented with LAB (CRD-CRL1446, 
CRD-CRL1434 and CRD-CRL431) compared with CRD group. In this regard, the 
CRL431 showed the highest capability of induction of TNF-α, and CRL1434 of IL-10. 
On the other hand, the levels of MCP-1 were significantly higher in the groups 
supplemented with CRL431 and CRL1434 strains, compared with the CRD group at 
day 20, this strains reached levels similar to the SD control. 
On the other hand, the levels of MCP-1 were significantly lower in the groups 
supplemented with CRL1446 and CRL1434 strains, compared with the CRD group, 
while in the CRD-CRL431 group the levels were similar to the SD control.  
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After LPS stimulus at days 20 and 45 of treatment, groups CR-CRL1434 and CR-
CRL431 had the higher IL-10 levels. Regarding TNF-α levels, both the CR-CRL431 
and CR-CRL1434 groups showed a significant increase in this cytokine at day 45. 
While for IL-6, only the CR-CRL431 group differed significantly with respect to CRD 
group. Finally, we only observed significant changes with CR-CRL1434 and CR-
CRL431 at day 20.  
These results demonstrate a strong immune- and adipo-modulatory effect of LAB on 
macrophages and adipocytes, which was also strain dependent. We observe increases in 
the levels of IL-10 (mainly in CR-CRL1434 group), TNF-α, and IL-6 (mainly in CR-
CRL431 group). 
3.5. Effect of the CR diet and LAB administration on the composition of the 
intestinal microbiota (IM) 
The microbial communities present in the mice faecal samples of the different groups 
were analysed by massive and parallel sequencing of 16S rDNA amplicons (Fig.6). Our 
results represent an evidence of the LAB effect associated to CRD on IM, which was 
also strain-dependent and it may not be generalized at the genus level. Some alpha 
diversity parameters were showed in Table 1. The observed richness (rarefaction 
analysis) shows that there were not great differences in the IM from the different 
groups. However, all CRD groups showed a tendency to a smaller number of gut 
microbial species when compared with the SD group (Sobs index). Interestingly, the 
CRD seems to induce a diversity gain in terms of homogeneity of the microbial 
communities, since it increased the Shannon index over time. This was supported by the 
inverse of the Simpson index (1/Simpson index indicates microbial diversity), since we 
determined that the CRD for day 45 induce an increase of almost twice (11.8) of the 
microbial diversity observed at day 20 (6.21). The supplementation of the CRD with 
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CRL1446 and CRL431 reduced the biodiversity, mainly due to the increase of the 
dominance of specific species in the microbial community. This assessment was 
demonstrated by the augment of the Simpson index and decline of the Shannon index, 
with respect to the other treatments. 
Our results demonstrate important changes in the composition of the IM (both phyla and 
genus) in the study groups (Fig. 6 A-D). The CRD induce changes in the relative 
abundance of specific groups of bacteria in the faecal content of the mice. Thus, this 
diet favorous a reduction of the phyla related to pathogens, such as Proteobacteria and 
TM7 compared with the SD.  In addition, the CRD induced an increase of Bacteroidetes 
and Actinobacteria phyla (but this last phylum decreased over time). Firmicutes showed 
no significant changes between the SD and CRD groups. Consequently, CRD 
significantly reduced the Firmicutes/Bacteroidetes ratio (F/B) (Fig. 6E and 6F) with 
respect to the SD. This is in agreement with other authors, who used other restrictive 
treatments, such as bariatric surgery (Damms-Machado et al., 2015). This reduction in 
the index F/B is probably related to the energy extraction by the host (Jumpertz et al., 
2011). Previous research have demonstrated that the Firmicutes phylum favorous the 
extraction of energy from the diet (Flint, Scott, Duncan, Louis, & Forano, 2012; 
Krajmalnik-Brown et al., 2012), this reduction in Firmicutes phylum was greater when 
we supplemented the CRD with CRL1446 (day 20), whereas CRL431 induced an 
opposite effect, increasing the levels of the F/B index (day 20) (Fig. 6E and 6F). The 
species belonging to the phylum Firmicutes have demonstrated a great capacity to 
degrade the polysaccharides of the diet and favour the absorption of sugars and other 
metabolites (Flint et al., 2012; Krajmalnik-Brown et al., 2012), thus maximizing the 
energy supply provided by the diet (Jumpertz et al., 2011). We could suggest that the 
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effect of the dietary treatments on the F/B index partially explain the changes on the 
AT, the profile of adipokines, BWG, and the biochemical parameters observed. 
The CRD induced an increase of Bifidobacterium and Lactobacillus genera, which 
accounted between 60% and 70% of the total microbiota of this group. Barnesiella, is 
another genus that showed an increase due to CRD. Zhang et al., reported that the CRD 
enriches the IM with filotypes that correlate positively with the half-life, for example 
the Lactobacillus genus, and decrease those that correlate negatively, such as 
opportunistic pathogens (Zhang et al., 2013). 
In CRD-CRL1446 group, we observed a F/B ratio reduction associated to a reduction of 
the phylum Firmicutes and Lactobacillus.  However, it was the only group that no 
change the levels of Lactobacillus during the treatment. In another groups, with the 
exception of CRD-CRL431 group, a decrease of the Lactobacillus number was 
observed at days 20 and 45. Contrariwise, the supplementation with L. casei CRL431 
induced higher levels of this genus at both days 20 and 45. In addition, the CR-CRL431 
group showed the highest value of the F/B ratio at day 20.  
The increase of Actinobacteria phylum was observed in CR-CRL1446 group with a 
significant increase in the relative abundance of the Bifidobacterium genus (≈ 50% of 
the microbial community at day 45). As was previously reported, this results 
demonstrate a bifidogenic effect for the CRD combined with the supplementation of 
CRL1446  (Russo et al., 2016). Zhang et al. (2013) suggested that under conditions of 
restricted nutrient availability, as occurs in CRD, the organism can extract nutrients 
more efficiently from proteins and fats, leaving an abundant proportion of indigestible 
plant and polysaccharides in relation to other sources of energy in the colon (Zhang et 
al., 2013). This statement could explain the increase in the abundance of bifidobacteria 
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by CRD, that relies on the bifidogenic effect reported for dietary fiber (Davis, Martínez, 
Walter, Goin, & Hutkins, 2011). 
The supplementation of the CRD with L. casei CRL431 induced a significant increase 
of the phylum Firmicutes at day 20 of treatment, accompanied with an increase of the 
Lactobacillus genus (70% of the IM). The genera Lactobacillus and Bifidobacterium are 
responsible for beneficial effects on the host (Saez-Lara, Gomez-Llorente, Plaza-Diaz, 
& Gil, 2015), could represent another mechanism by which the CR diet extends the 
average life of an individual, this due to the known capacity of these LAB to inhibit the 
adhesion of pathogens to the intestinal wall, protect the alteration of the intestinal 
barrier, improve intestinal transit, among others.  
Finally, the CR-CRL1434 group did not show significant differences in the composition 
of the microbiota (phylum and genus) with respect to the CRD group. 
4. Conclusions 
The CRD had a significant effect on IM composition. In addition, the supplementation 
of the CRD with specific LAB can modify the effects of this diet on the IM 
composition. This study reports a bifidogenic effect associated with the CRD, which 
was higher after the supplementation with L. fermentum CRL1446. Thereby, the CRD 
supplemented with LAB could represent an effective treatment to promote the growth of 
intestinal beneficial bacteria and improve the health of the host. L. fermentum CRL1446 
and Lac. lactis CRL1434 could be potentially probiotic strains to improve the immuno-
metabolic alterations associated with obesity. While, L. casei CRL431 could be used in 
cases of undernourishment, where this strain could improve the absorption of nutrients 
and protection against infections, further the stimulation of the immune system. 
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FIGURE LEYENDS 
Figure 1. Body weight gain (A) and feed conversion ratio (FCR) (B) in mice at days 7, 
20 and 45  after the dietary intervention with a caloric restriction diet (CRD) with and 
without administration of L. fermentum CRL1446 (CRD-CRL1446), Lac. lactis 
CRL1434 (CRD-CRL1434) and L. casei CRL431 (CRD-CRL431) at a dose of 1x10
8
 
CFU/mL. Controls mice were fed with standard diet (SD) or CRD without bacterial 
supplementation. The FCR is the relation between the food consumed (g) and the body 
weight gain (g) expressed as a percentage. Each group of data is represented by the 
mean ± SEM (standard error mean). In the same period of treatment (day 7, 20 or 45), 
data with different lowercase letters (a–d), data with different lowercase letter with 
apostrophe (a’-e’) and data with different uppercase letters (A-E) are significantly 
different (P < 0.05) according to ANOVA statistical analysis. 
Figure 2. Relative weight of adipose tissue (AT) at days 20 and 45 (A), distribution of 
adipocyte size at day 20 (B), and distribution of adipocyte size at day 45 (C) after the 
dietary intervention with a caloric restriction diet (CRD) with and without 
administration of L. fermentum CRL1446 (CRD-CRL1446), Lac. lactis CRL1434 
(CRD-CRL1434) and L. casei CRL431 (CRD-CRL431) at a dose of 1x10
8
 CFU/mL. 
Adipocyte cell sizes are expressed as area ranges as follows: <500, 500-1000, 1000-
2000, and 2000-4000 µm
2
. Photomicrographs 40X of representative HE-stained slides 
of AT at day 45 are shown. Data are represented by the mean ± SEM (standard error 
mean). In Figure A, data with different lowercase letters (a–c) and data with different 
uppercase letters (A-C) at the same period of treatment (day 20 or 45) are significantly 
different (P < 0.05). In Figure B and C, data with different lowercase letters (a,b) in the 
same adipocyte cell sizes (area ranges) are significantly different (P< 0.05). These 
evaluations were carried out using ANOVA statistical analysis. 
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Figure 3. Plasma levels of glucose (A), total cholesterol (B), triglycerides (C)  and 
leptin (D) at days 20 and 45 after the dietary intervention with a caloric restriction diet 
(CRD) with and without administration of L. fermentum CRL1446 (CRD-CRL1446), 
Lac. lactis CRL1434 (CRD-CRL1434) and L. casei CRL431 (CRD-CRL431) at a dose 
of 1x10
8
 CFU/mL. Data are represented by the mean ± SEM (standard error mean). In 
the same period of treatment (day 20 or 45), data with different lowercase letters (a–c), 
and data with different uppercase letters (A-D) are significantly different (P < 0.05) 
according to ANOVA statistical analysis. 
Figure 4. Plasma levels of pro-inflammatory TNF-α (A) and anti-inflammatory IL-10 
(B) cytokines at days 20 and 45 after the dietary intervention with a caloric restriction 
diet (CRD) with and without administration of L. fermentum CRL1446 (CRD-
CRL1446), Lac. lactis CRL1434 (CRD-CRL1434) and L. casei CRL431 (CRD-
CRL431) at a dose of 1x10
8
 CFU/mL. Data are represented by the mean ± SEM 
(standard error mean). Data with different lowercase letters (a–d) at day 45 are 
significantly different (P < 0.05) according to ANOVA statistical analysis. 
Figure 5. Levels of leptin (A, B) produced by LPS-stimulated or non-stimulated ex vivo 
epididymal adipocytes at days 20 and 45; and levels of TNF-α (C, D), IL-6 (E, F), 
MCP-1 (G, H) and IL-10 (I, J) produced by LPS-stimulated or non-stimulated ex vivo 
peritoneal macrophages at days 20 and 45. The cells were obtained from mice after the 
dietary intervention with a caloric restriction diet (CRD) with and without 
administration of L. fermentum CRL1446 (CRD-CRL1446), Lac. lactis CRL1434 
(CRD-CRL1434) and L. casei CRL431 (CRD-CRL431) at a dose of 1x10
8
 CFU/mL.  
DEMEN or control (-): basal levels of leptin, TNF-α, IL-6, MCP-1 IL-10 produced by 
epididymal adipocytes or peritoneal macrophages without any stimulus. LPS or control 
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(+): epididymal adipocytes or peritoneal macrophages stimulated with LPS. Data are 
represented by the mean ± SEM (standard error mean).  At day 20 or 45, in cells without 
stimulus (DEMEN) and  cells with stimulus (LPS), data with different lowercase letters 
(a–c), and data with different uppercase letters (A-E) are significantly different (P < 
0.05) according to ANOVA statistical analysis. 
Figure 6 Relative abundance (%) of the phila (A, B) and genera (C, D) and F/B index 
(Firmicutes /Bacteroidetes ratio) (E, F) in the intestinal faecal content of mice after the 
dietary intervention with a caloric restriction diet (CRD) with and without 
administration of L. fermentum CRL1446 (CRD-CRL1446), Lac. lactis CRL1434 
(CRD-CRL1434) and L. casei CRL431 (CRD-CRL431) at a dose of 1x10
8
 CFU/mL. 
The microbial communities present in the mice faecal samples of the different groups 
were analysed by massive and parallel sequencing of 16S rDNA amplicons. Each group 
of data represents the average of 6 mice and the 20 main generes that represent more 
than 99% of the intestinal microbiota are presented. 
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Table 1 Common ecological parameters of alpha diversity for the microbial 
communities analysed. 
The data were obtained from mice after the dietary intervention at 20 and 45 days of 
standard diet (SD), or a caloric restriction diet (CRD) with and without administration 
of L. fermentum CRL1446 (CRD-CRL1446), Lac. lactis CRL1434 (CRD-CRL1434) 
and L. casei CRL431 (CRD-CRL431) at a dose of 1x10
8
 CFU/mL.   
  
Experimental groups  Alpha diversity coefficients 
days Distance Sobs Shannon Simpson 
SD 20 0,0300 1374 3,6777 0,0836 
 45 0,0300 1400 3,4771 0,1963 
CR 20 0,0300 1275 3,0224 0,1609 
 45 0,0300 1399 3,6284 0,0848 
CR-CRL1446  20 0,0300 1269 2,7711 0,2049 
 45 0,0300 1193 2,2196 0,2742 
CR-CRL1434 20 0,0300 1235 3,4516 0,0988 
 45 0,0300 1474 3,7409 0,0740 
CR-CRL431 20 0,0300 1133 2,3185 0,2650 
 45 0,0300 1249 2,7095 0,2454 
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Highlights 
 Caloric restriction and lactic bacteria change gut microbiota composition in mice 
 Caloric restriction and lactic bacteria modulate immune-metabolic parameters in 
mice 
 The immune-metabolic effects of the lactic bacteria are strain-dependent 
 L. fermentum CRL1446 has bifidogenic effect. 
 L. fermentum CRL1446 displays hypocholesterolemic and hypoglycemic 
properties 
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